PMID: 6982044Sep 1, 1982Paper

Gamma-carboxyglutamate excretion and calcinosis in juvenile dermatomyositis

Arthritis and Rheumatism
J B LianM C Maryjowski

Abstract

Proteins containing gamma-carboxyglutamic acid (Gla) are present in subcutaneous calcifications of adults with dermatomyositis or scleroderma. Sixteen children with juvenile dermatomyositis, including 7 with subcutaneous calcifications, were studied to determine if abnormal synthesis or turnover of Gla-containing proteins occurred. All study children had increased excretion of the amino acid that was greater than that of age- and sex-matched controls. Patients who had juvenile dermatomyositis with calcifications had a 3-fold increase in Gla excretion, and those without calcinosis had a 2-fold increase. Five other children with various connective tissue disorders and subcutaneous calcification had 2-fold increased Gla excretion. Decreased excretion of this amino acid was associated with salicylate therapy (80 mg/kg/24 hours). The data suggest an abnormal turnover of Gla-containing proteins in juvenile dermatomyositis. Metabolism of these proteins may be involved in the pathophysiology of soft-tissue calcification in children.

References

Aug 23, 1976·Biochemical and Biophysical Research Communications·P V HauschkaP M Gallop
Nov 14, 1979·Biochemical and Biophysical Research Communications·R J LevyP Gallop
Oct 1, 1976·Neurology·S CarpenterG Watters
Jan 1, 1977·Annual Review of Biochemistry·J Stenflo, J W Suttie
May 1, 1979·Clinical Pharmacology and Therapeutics·R J Levy, J B Lian
Jun 1, 1977·The Journal of Clinical Investigation·J B LianP M Gallop
May 15, 1977·Analytical Biochemistry·P V Hauschka
Oct 1, 1976·Clinica Chimica Acta; International Journal of Clinical Chemistry·P Fernlund
Nov 22, 1976·Biochemical and Biophysical Research Communications·J B LianP Gallop
Oct 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·P V HauschkaP M Gallop
May 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·P A PriceN Raman
Feb 20, 1975·The New England Journal of Medicine·A Bohan, J B Peter
Feb 13, 1975·The New England Journal of Medicine·A Bohan, J B Peter
Jul 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·J StenfloP Roepstorff
Jul 30, 1981·The New England Journal of Medicine·R A BlanchardB Furie
Oct 1, 1981·Human Immunology·T J HirschF C Arnett
Feb 1, 1980·The Journal of Pediatrics·L M Pachman, N Cooke
Apr 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·P A Price, S K Nishimoto
Jun 26, 1980·The New England Journal of Medicine·P M GallopP V Hauschka
Feb 1, 1980·The Journal of Clinical Investigation·R J LevyJ B Lian

❮ Previous
Next ❯

Citations

Mar 1, 1983·Clinica Chimica Acta; International Journal of Clinical Chemistry·C M GundbergP M Gallop
Apr 1, 1990·The Journal of Pediatrics·A ReedC B Langman
Aug 20, 2002·The Journal of Dermatology·Akiyo GushiTamotsu Kanzaki
Jun 9, 2005·Seminars in Arthritis and Rheumatism·Nina BoulmanItzhak Rosner
Apr 1, 2009·Arthritis and Rheumatism·Annette L UrganusLauren M Pachman
Jun 1, 1983·Archives of Disease in Childhood·G MillerV Dubowitz
Aug 24, 2016·Journal of Clinical Neuromuscular Disease·Hafiz A ElahiJohn N Whitaker
Feb 9, 2021·Current Rheumatology Reports·Ovgu Kul CinarClarissa A Pilkington
Oct 1, 1989·Seminars in Arthritis and Rheumatism·P J Rush
Aug 1, 1986·Seminars in Arthritis and Rheumatism·V K Rocco, E R Hurd
Dec 8, 1998·Journal of the American Academy of Dermatology·S O Kovacs, S C Kovacs

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.